{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:43:35Z","timestamp":1762375415631},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T00:00:00Z","timestamp":1275523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00228-010-0839-9","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T05:32:45Z","timestamp":1275456765000},"page":"911-917","source":"Crossref","is-referenced-by-count":9,"title":["Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up"],"prefix":"10.1007","volume":"66","author":[{"given":"P\u00e5l","family":"Gjerden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Sl\u00f8rdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,3]]},"reference":[{"key":"839_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","volume":"100","author":"R Tandon","year":"2008","unstructured":"Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ Jr, Okasha A, Singh B, Stein DJ, Olie J-P, Fleishhacker WW, Moeller H-J (2008) World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res 100:20\u201338","journal-title":"Schizophr Res"},{"key":"839_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1751-7893.2008.00103.x","volume":"3","author":"S Opjordsmoen","year":"2009","unstructured":"Opjordsmoen S, Melle I, Friis S, Haahr U, Johannessen JO, Larsen TK, Rund BR, Simonsen E, Vaglum P, McGlashan TH (2009) Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics. Early Interv Psychiatry 3:58\u201365","journal-title":"Early Interv Psychiatry"},{"key":"839_CR3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","volume":"165","author":"L Sikich","year":"2008","unstructured":"Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RA, Lieberman JA (2008) Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 165:1420\u20131431","journal-title":"Am J Psychiatry"},{"key":"839_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-244X-8-32","volume":"8","author":"G Morken","year":"2008","unstructured":"Morken G, Widen JH, Grawe RW (2008) Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry 8:32. doi: 10.1186\/1471-244X-8-32","journal-title":"BMC Psychiatry"},{"issue":"7","key":"839_CR5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0149-2918(08)80062-8","volume":"30","author":"FD Gianfresco","year":"2008","unstructured":"Gianfresco FD, Sajatovic M, Rajagopalan K, Wang R-H (2008) Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther 30(7):1358\u20131374","journal-title":"Clin Ther"},{"issue":"2","key":"839_CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","volume":"163","author":"S Heres","year":"2006","unstructured":"Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S (2006) Why olanzapine beats risperidone, risperidone beats quetiapine and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 163(2):185\u2013195","journal-title":"Am J Psychiatry"},{"key":"839_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31\u201341","journal-title":"Lancet"},{"key":"839_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/j.2051-5545.2009.tb00200.x","volume":"8","author":"WW Fleischacker","year":"2009","unstructured":"Fleischacker WW, Goodwin GM (2009) Effectiveness as an outcome measure for treatment trials in psychiatry. World Psychiatry 8:23\u201327","journal-title":"World Psychiatry"},{"key":"839_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/apt.bp.107.003970","volume":"14","author":"DC Owens","year":"2008","unstructured":"Owens DC (2008) How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia. Adv Psychiatr Treat 14:17\u201328","journal-title":"Adv Psychiatr Treat"},{"issue":"3","key":"839_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3371\/CSRP.2.3.4","volume":"2","author":"H Ascher-Svanum","year":"2008","unstructured":"Ascher-Svanum H, Nyhuis AW, Faries DE, Heiler L, Kinon BJ (2008) Treatment discontinuation following randomization to open-label olanzapine, risperidone or typical antipsychotics during a one-year treatment for schizophrenia. Clin Schizophr Relat Psychoses 2(3):226\u2013234","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"839_CR11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.jcp.0000245563.06660.0f","volume":"26","author":"BJ Kinon","year":"2006","unstructured":"Kinon BJ, Liu-Seifert H, Adams DH, Citrome L (2006) Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. J Clin Psychopharmacol 26:632\u2013637","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"839_CR12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00228-009-0696-6","volume":"65","author":"P Gjerden","year":"2009","unstructured":"Gjerden P, Sl\u00f8rdal L, Bramness JG (2009) Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents. Eur J Clin Pharmacol 65(12):1229\u20131235","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 2","key":"839_CR13","first-page":"S48","volume":"14","author":"K Furu","year":"2005","unstructured":"Furu K, Str\u00f8m H, R\u00f8nning M, Skurtveit S, Engedal A, Tverdal A (2005) The Norwegian Prescription database (NorPD): new register for pharmacoepidemiological research covering a whole nation. Pharmacoepidemiol Drug Safe 14(Suppl 2):S48","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"839_CR14","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2005) Guidelines for ATC classification and DDD assignment. WHO, Oslo"},{"key":"839_CR15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00019442-200407000-00012","volume":"12","author":"HA Nasrallah","year":"2004","unstructured":"Nasrallah HA, White T, Nasrallah AT (2004) Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. Am J Geriatr Psychiatry 12:437\u2013439","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11\u201312","key":"839_CR16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/j.1440-1614.2006.01920.x","volume":"40","author":"J Hollis","year":"2006","unstructured":"Hollis J, Touyz S, Grayson D, Forrester L (2006) Antipsychotic medication dispensing and associated odds ratios of death in elderly veterans and war widows. Aust N Z J Psychiatry 40(11\u201312):981\u2013986","journal-title":"Aust N Z J Psychiatry"},{"key":"839_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f8nnquist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J (2009) 11-year follow-up of mortality in patients with scicophrenia: a population-based cohort study (FIN11 study). Lancet 374:620\u2013627","journal-title":"Lancet"},{"key":"839_CR18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","volume":"60","author":"JA Lieberman","year":"2008","unstructured":"Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li X-M, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG (2008) Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation and neuroprotection. Pharmacol Rev 60:358\u2013403","journal-title":"Pharmacol Rev"},{"issue":"4","key":"839_CR19","first-page":"329","volume":"25","author":"F Casadebaig","year":"1999","unstructured":"Casadebaig F, Philippe A (1999) Mortality among schizophrenic patients. Encephale 25(4):329\u2013337","journal-title":"Encephale"},{"key":"839_CR20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1176\/appi.ajp.160.3.574","volume":"160","author":"M Vythilingam","year":"2003","unstructured":"Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, Nelson JC (2003) Psychotic depression and mortality. Am J Psychiatry 160:574\u2013576","journal-title":"Am J Psychiatry"},{"key":"839_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/pds.1756","volume":"18","author":"SR Kjosavik","year":"2009","unstructured":"Kjosavik SR, Ruths S, Hunskaar S (2009) Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database. Pharmacoepidemiol Drug Safe 18:572\u2013578","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"839_CR22","unstructured":"van Kammen DP, Marder SR (2005) Serotonin-dopamine antagonists (atypical or second-generation antipsychotics). In: Sadock JB, Sadock VA (eds) Kaplan & Sadock\u2019s comprehensive textbook of psychiatry. Lippincott Williams & Wilkins, Philadelphia, pp 2914\u20132938"},{"issue":"1","key":"839_CR23","first-page":"53","volume":"118","author":"P Gjerden","year":"1998","unstructured":"Gjerden P, Sl\u00f8rdal L (1998) Antikolinerge antiparkinsonmedikamenters kliniske farmakologi. Tidsskr Nor Laegeforen 118(1):53\u201355","journal-title":"Tidsskr Nor Laegeforen"},{"key":"839_CR24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bmj.322.7284.444","volume":"322","author":"M Stewart","year":"2001","unstructured":"Stewart M (2001) Towards a global definition of patient centred care. BMJ 322:444\u2013445","journal-title":"BMJ"},{"key":"839_CR25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1176\/ps.2006.57.11.1636","volume":"57","author":"PE Deegan","year":"2006","unstructured":"Deegan PE, Drake RE (2006) Shared decision making and medication management in the recovery process. Psychiatr Serv 57:1636\u20131638","journal-title":"Psychiatr Serv"},{"key":"839_CR26","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1990) Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on aspects of mental illness. Br J Psychiatry 156:412","DOI":"10.1192\/bjp.156.3.412"},{"key":"839_CR27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2753.2007.00912.x","volume":"14","author":"P Gjerden","year":"2008","unstructured":"Gjerden P, Bramness JG, Sl\u00f8rdal L (2008) Effect of warnings in a medical journal on the use of orphenadrine. J Eval Clin Pract 14:615\u2013617","journal-title":"J Eval Clin Pract"},{"key":"839_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08039480600636494","volume":"60","author":"I Castberg","year":"2006","unstructured":"Castberg I, Reimers A, Sandvik P, Aamo T, Spigset O (2006) Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists. Nord J Psychiatry 60:227\u2013233","journal-title":"Nord J Psychiatry"},{"key":"839_CR29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4088\/JCP.v68n0601","volume":"68","author":"D Cooper","year":"2007","unstructured":"Cooper D, Moisan J, Gregoire J-P (2007) Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia. J Clin Psychiatry 68:818\u2013825","journal-title":"J Clin Psychiatry"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0839-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-010-0839-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0839-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T15:27:34Z","timestamp":1559143654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-010-0839-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,3]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s00228-010-0839-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,3]]}}}